Therapeutic monoclonal antibodies in allergy: Targeting IgE, cytokine, and alarmin pathways

A Eggel, LF Pennington, TS Jardetzky - Immunological reviews, 2024 - Wiley Online Library
The etiology of allergy is closely linked to type 2 inflammatory responses ultimately leading
to the production of allergen‐specific immunoglobulin E (IgE), a key driver of many allergic …

Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell‐mediated diseases

M Metz, P Kolkhir, S Altrichter, F Siebenhaar… - Allergy, 2024 - Wiley Online Library
Chronic urticaria (CU) is a mast cell (MC)‐dependent disease with limited therapeutic
options. Current management strategies are directed at inhibiting IgE‐mediated activation of …

Gut microbiota facilitate chronic spontaneous urticaria

L Zhu, X Jian, B Zhou, R Liu, M Muñoz, W Sun… - Nature …, 2024 - nature.com
Chronic spontaneous urticaria (CSU) comes with gut dysbiosis, but its relevance remains
elusive. Here we use metagenomics sequencing and short-chain fatty acids metabolomics …

Controlled adsorption of multiple bioactive proteins enables targeted mast cell nanotherapy

F Du, CH Rische, Y Li, MP Vincent… - Nature …, 2024 - nature.com
Protein adsorption onto nanomaterials often results in denaturation and loss of bioactivity.
Controlling the adsorption process to maintain the protein structure and function has …

Sequence variant affects GCSAML splicing, mast cell specific proteins, and risk of urticaria

RP Kristjansson, GR Oskarsson, A Skuladottir… - Communications …, 2023 - nature.com
Urticaria is a skin disorder characterized by outbreaks of raised pruritic wheals. In order to
identify sequence variants associated with urticaria, we performed a meta-analysis of …

Siglecs as potential targets of therapy in human mast cell-and/or eosinophil-associated diseases

JA O'Sullivan, BA Youngblood, RP Schleimer… - Seminars in …, 2023 - Elsevier
Siglecs (sialic acid-binding immunoglobulin-like lectins) are a family of vertebrate glycan-
binding cell-surface proteins. The majority mediate cellular inhibitory activity once engaged …

Siglecs in allergy and asthma

BS Bochner, JA O'Sullivan, AT Chang… - Molecular aspects of …, 2023 - Elsevier
The term “allergic diseases” encompasses several common, IgE-mediated conditions that
range from being annoying to those that are life-threatening. Available treatments include …

Discovery of an agonistic Siglec-6 antibody that inhibits and reduces human mast cells

J Schanin, W Korver, EC Brock, J Leung… - Communications …, 2022 - nature.com
Mast cells (MC) are key drivers of allergic and inflammatory diseases. Sialic acid-binding
immunoglobulin-like lectin (Siglec)-6 is an immunoregulatory receptor found on MCs. While …

Human lung mast cells: therapeutic implications in asthma

R Poto, G Criscuolo, G Marone, CE Brightling… - International Journal of …, 2022 - mdpi.com
Mast cells are strategically located in different compartments of the lung in asthmatic
patients. These cells are widely recognized as central effectors and immunomodulators in …

A synthesis and subgroup analysis of the eosinophilic esophagitis tissue transcriptome

J Jacobse, R Brown, F Revetta, M Vaezi… - Journal of Allergy and …, 2024 - Elsevier
Background Eosinophilic esophagitis (EoE) is a chronic immune mediated inflammatory
disorder of the esophagus. It is still unknown why children and adults present differently, and …